Alnylam Reports Updated Positive Results from Phase 1/2 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 Read more
Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 as a Potential Treatment for MSA Read more
Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidates Read more
Therapure Biomanufacturing Announces U.S. FDA Approval for Manufacturing of Its Partner Insmed’s ARIKAYCE Read more
Horizon enters into license agreement with Cytovance for HD-BIOP3 Suspension adapted GS null CHO K1 cells Read more
Aptar Pharma Launches PureHale, a New Portable and Ready-to-Use Upper Respiratory Drug Delivery Solution Read more
Pharma Giants Collaboration Accelerates Access to Rare Disease Treatment – Hear more at Orphan Drugs & Rare Diseases 2018 Read more